Terrie Curran - Insider Trading & Ownership

Entity
Individual
Location
C/O Myovant Sciences Inc., 320 West 37 Th Street, 5 Th Floor, New York, NY
Summary
The estimated net worth of Terrie Curran is at least $4.58M dollars as of November 13, 2024. Terrie Curran is the President and Chief Executive, Director of Phathom Pharmaceuticals, Inc. and owns shares of Phathom Pharmaceuticals, Inc. (PHAT) stock worth about $4.47M. Terrie Curran is the Director of Arcutis Biotherapeutics, Inc. and owns shares of Arcutis Biotherapeutics, Inc. (ARQT) stock worth about $110K.
All Insider Reports
All Insider Reports

Ownership of Terrie Curran

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
PHAT Phathom Pharmaceuticals, Inc. President and Chief Executive, Director $4.47M -$550K -11% Jul 15, 2024
ARQT Arcutis Biotherapeutics, Inc. Director $110K -$94.2K -46.1% Nov 11, 2024
MYOV Myovant Sciences Ltd. Director Mar 10, 2023

Insider Transactions Reported by Terrie Curran:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.